However, even though ADAMTS13 differences were originally described, not all patients presenting with the clinical diagnosis of TTP have a deficiency in this metalloprotease leading to the suggestion that it lacks importance in the diagnostic workup of these disease entities [6], and as predictor of clinical response to therapy which should be based mostly on clinical criteria [7]. Here, ADAMTS13 is linked to thrombotic thrombocytopenic purpura.